US2002053548A1PendingUtilityA1

Leukocyte reduction filtration media

40
Assignee: WHATMAN HEMASURE INCPriority: Mar 8, 1999Filed: Nov 27, 2001Published: May 9, 2002
Est. expiryMar 8, 2019(expired)· nominal 20-yr term from priority
B01D 2239/064Y10T428/25B01D 2239/0216Y10T428/254B01D 39/163B01D 39/1661B01D 39/2024
40
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A high capacity leukocyte depletion filtration media incorporates a high specific surface area components with a matrix of fibers, yielding a filtration medium that removes leukocytes by at least 99.99%. The filtration medium uses a significantly low weight ratio of high specific surface area components to the matrix of fibers. The high specific area creates a multitude of adhesion sites for leukocytes while the low weight ratios allow good filtration flow rates. The filtration medium is incorporated into a filter device for removing leukocytes from biological fluids.

Claims

exact text as granted — not AI-modified
We claim:  
     
         1 . A filtration media for depleting leukocytes from leukocyte-containing blood products, said filtration media comprising a matrix of fibers and a plurality of high specific surface area components distributed amongst the fibers, wherein the weight ratio of the high specific surface area components distributed amongst the matrix of fibers to the matrix of fibers is less than or equal to about 1:100, wherein use of said filtration media removes at least 99.99% of the leukocytes.  
     
     
         2 . The filtration media of  claim 1  wherein the weight ratio of the high specific area components distributed amongst the matrix of fibers to the matrix of fibers is less than about 1:150.  
     
     
         3 . The filtration media of  claim 2  wherein the weight ratio of the high specific area components distributed amongst the matrix of fibers to the matrix of fibers is less than about 1:200.  
     
     
         4 . The filtration media of  claim 1  wherein the matrix of fibers comprises glass fibers.  
     
     
         5 . The filtration media of  claim 1  wherein the components distributed amongst the matrix of fibers are highly fibrillated fibers or particles having a specific surface area of at least 100 m 2 /g.  
     
     
         6 . The filtration media of  claim 5 , wherein the surface area of the highly fibrillated fibers or particles is at least 120 m 2 /gm.  
     
     
         7 . The filtration media of  claim 5  wherein the highly fibrillated fibers or particles are comprised of a polyacrylonitrile copolymer.  
     
     
         8 . The filtration media of  claim 5  wherein the highly fibrillated fibers or particles comprise an acrylonitrile vinyl acetate copolymer.  
     
     
         9 . The filtration media of  claim 5  wherein the highly fibrillated fibers or particles have an average diameter of less than 0.05 μm.  
     
     
         10 . The filtration media of  claim 1 , further comprising a binder.  
     
     
         11 . The filtration media of  claim 10 , wherein the binder is polyvinyl alcohol or a cross-linked derivative thereof.  
     
     
         12 . A filtration media for depleting leukocytes from leukocyte-containing blood products, said filtration media comprising a matrix of glass fibers; a plurality of high specific surface area polyacrylonitrile copolymer highly fibrillated fibers or particles distributed amongst the glass fibers, wherein the weight ratio of the highly fibrillated fibers or particles to the matrix fibers is less than about 1:200; and a binder comprised of polyvinyl alcohol or a cross-linked derivative thereof.  
     
     
         13 . A method for depleting leukocytes from leukocyte-containing blood products, said method comprising passing the blood product through a leukocyte reduction filtration media comprised of a matrix of fibers and a plurality of high specific surface area components distributed amongst the matrix of fibers, wherein the weight ratio of the high surface area components distributed amongst the matrix fibers to the matrix fibers is less than or equal to about 1:100; removing at least 99.99% of the leukocytes from the blood product; and recovering a leukocyte-depleted blood product.  
     
     
         14 . The method of  claim 13  wherein the weight ratio of the high specific surface area components distributed amongst the matrix of fibers to the matrix of fibers is less than about 1:150.  
     
     
         15 . The method of  claim 14  wherein the weight ratio of the components distributed amongst the matrix of fibers to the matrix fibers is less than about 1:200.  
     
     
         16 . The method of  claim 14  wherein the matrix of fibers comprise glass fibers.  
     
     
         17 . The method of  claim 13  wherein the high specific surface area components distributed amongst the matrix of fibers are highly fibrillated fibers or particles having a specific surface area of at least 100 m 2 /g.  
     
     
         18 . The method of  claim 17  wherein the specific surface area of the highly fibrillated fibers or particles is at least 120 m 2 /gm.  
     
     
         19 . The method of  claim 17  wherein the highly fibrillated fibers or particles are comprised of a polyacrylonitrile copolymer.  
     
     
         20 . The method of  claim 17  wherein the highly fibrillated fibers or particles comprise an acrylonitrile vinyl acetate copolymer.  
     
     
         21 . The method of  claim 13  wherein the filtration medium further comprises a binder.  
     
     
         22 . The method of  claim 21  wherein the binder is polyvinyl alcohol or a cross-linked derivative thereof.  
     
     
         23 . A filter device for depleting leukocytes from leukocyte-containing blood products, said device comprising a housing having an inlet and an outlet and having one or more layers of leukocyte depletion filtration media disposed therein, said media comprising a matrix of fibers and a plurality of high specific surface area components distributed amongst the matrix of fibers, wherein the weight ratio of high specific surface area components distributed amongst the matrix of fibers to the matrix of fibers is less than or equal to about 1:100 wherein use of said filtration device removes 99.99% of the leukocytes.  
     
     
         24 . The filter device of  claim 22  further comprising one or more layers of a prefilter media disposed within said housing upstream from said leukocyte depletion filtration media.  
     
     
         25 . The filter device of  claim 24  further comprising a particle trap is disposed within said housing downstream from said leukocyte depletion filtration media.  
     
     
         26 . The filter device of  claim 25  wherein the leukocyte depletion filtration media is comprised of a matrix of glass fibers and the high specific surface area components comprise a plurality of highly fibrillated polyacrylonitrile copolymer fibers and a binder.  
     
     
         27 . The filter device of  claim 26  wherein the binder is polyvinyl alcohol or a cross-linked derivative thereof.  
     
     
         28 . The filter device of  claim 26  wherein the prefilter media comprises a material capable of filtering gels.  
     
     
         29 . The filter device of  claim 27  wherein the prefilter medium comprises a needle-punched fabric, and wherein the particle trap comprises at least one layer of a polyester screen and at least one layer of a nonwoven fibrous web.  
     
     
         30 . The filter device of  claim 29  wherein the particle trap comprises at least one layer of a wet-laid polyethylene terephthalate medium and at least one thin polyester screen.  
     
     
         31 . A filter device for depleting leukocytes from leukocyte-containing blood products comprising: 
 a housing having an inlet and an outlet and having one or more layers of leukocyte depletion filtration media disposed therein, said media comprising a matrix of fibers and a plurality of high specific surface area components distributed amongst the matrix of fibers, wherein the weight ratio of the high specific surface area components to the matrix of fibers is less than about 1:200 and wherein during use said filtration media removes at least 99.99% of leukocytes;    a prefilter, located upstream of said one or more layers of leukocyte depletion media, having a layer of needle punched fabric; and    a particle trap located downstream of said one or more layers of leukocyte depletion media, having a first thin polyester screen, a layer of non-woven polyester, and a second thin polyester screen.    
     
     
         32 . A filtration media for depleting leukocytes from leucocyte-containing blood products, said filtration media comprising a matrix of fibers and a plurality of components having a specific surface area of at least 100 m 2 /gm distributed amongst components having a specific surface area of at least 100 m 2 /gm wherein use of said filtration media removes at least 99.99% of the leukocytes.  
     
     
         33 . The filtration media of  claim 32  wherein the weight ratio of the high specific surface area components distributed amongst the matrix of fibers to the matrix of fibers is less than or equal to about 1:100.  
     
     
         34 . The filtration media of  claim 32  wherein the weight ratio of the high specific area components distributed amongst the matrix of fibers to the matrix of fibers is less than about 1:150.  
     
     
         35 . The filtration media of  claim 32  wherein the weight ratio of the high specific area components distributed amongst the matrix of fibers to the matrix of fibers is less than about 1:200.  
     
     
         36 . The filtration media of  claim 32  wherein the matrix of fibers comprises glass fibers.  
     
     
         37 . The filtration media of  claim 32  wherein the components distributed amongst the matrix of fibers are highly fibrillated fibers or particles.  
     
     
         38 . The filtration media of  claim 37 , wherein the surface area of the highly fibrillated fibers or particles is at least 120 m 2 /gm.  
     
     
         39 . The filtration media of  claim 37  wherein the highly fibrillated fibers or particles are comprised of a polyacrylonitrile copolymer.  
     
     
         40 . The filtration media of  claim 37  wherein the highly fibrillated fibers or particles comprise an acrylonitrile vinyl acetate copolymer.  
     
     
         41 . The filtration media of  claim 37  wherein the highly fibrillated fibers or particles have an average diameter of less than 0.05 μm.  
     
     
         42 . The filtration media of  claim 32 , further comprising a binder.  
     
     
         43 . The filtration media of  claim 42  wherein the binder is polyvinyl alcohol or a cross-linked derivative thereof.  
     
     
         44 . A filtration media for depleting leukocytes from leukocyte-containing blood products, said filtration media comprising a matrix of glass fibers; a plurality of polyacrylonitrile copolymer highly fibrillated fibers or particles having a specific surface area of at least 120 m 2 /gm distributed amongst the glass fibers; and a binder comprised of polyvinyl alcohol or a cross-linked derivative thereof.  
     
     
         45 . A method for depleting leukocytes from leukocyte-containing blood products, said method comprising passing the blood product through a leukocyte reduction filtration media comprised of a matrix of fibers and a plurality of high specific surface area components distributed amongst the matrix of fibers having a specific surface area of at least 100 m 2 /gm; removing at least 99.99% of the leukocytes from the blood product; and recovering a leukocyte-depleted blood product.  
     
     
         46 . The method of  claim 45  wherein the high specific surface area components distributed amongst the matrix of fibers are highly fibrillated fibers or particles.  
     
     
         47 . The method of  claim 46  wherein the specific surface area of the highly fibrillated fibers or particles is at least 120 m 2 /gm.  
     
     
         48 . The method of  claim 46  wherein the highly fibrillated fibers or particles are comprised of a polyacrylonitrile copolymer.  
     
     
         49 . The method of  claim 46  wherein the highly fibrillated fibers or particles comprise an acrylonitrile vinyl acetate copolymer.  
     
     
         50 . The method of  claim 45  wherein the matrix of fibers comprise glass fibers.  
     
     
         51 . The method of  claim 45  wherein the weight ratio of the high specific surface area components distributed amongst the matrix of fibers to the matrix of fibers is less than or equal to about 1:100.  
     
     
         52 . The method of  claim 51  wherein the weight ratio of the components distributed amongst the matrix of fibers to the matrix fibers is less than about 1:150.  
     
     
         53 . The method of  claim 45  wherein the filtration medium further comprises a binder.  
     
     
         54 . The method of  claim 53  wherein the binder is polyvinyl alcohol or a cross-linked derivative thereof.  
     
     
         55 . A filter device for depleting leukocytes from leukocyte-containing blood products, said device comprising a housing having an inlet and an outlet and having one or more layers of leukocyte depletion filtration media disposed therein, said media comprising a matrix of fibers and a plurality of high components distributed amongst the matrix of fibers having a specific surface area of at least 100 m 2 /gm wherein use of said filtration device removes 99.99% of the leukocytes.  
     
     
         56 . The filter device of  claim 55  further comprising one or more layers of a prefilter media disposed within said housing upstream from said leukocyte depletion filtration media.  
     
     
         57 . The filter device of  claim 56  further comprising a particle trap is disposed within said housing downstream from said leukocyte depletion filtration media.  
     
     
         58 . The filter device of  claim 57  wherein the leukocyte depletion filtration media is comprised of a matrix of glass fibers and the high specific surface area components comprise a plurality of highly fibrillated polyacrylonitrile copolymer fibers and a binder.  
     
     
         59 . The filter device of  claim 58  wherein the binder is polyvinyl alcohol or a cross-linked derivative thereof.  
     
     
         60 . The filter device of  claim 58  wherein the prefilter media comprises a material capable of filtering gels.  
     
     
         61 . The filter device of  claim 59  wherein the prefilter medium comprises a needle-punched fabric, and wherein the particle-trap comprises at least one layer of a polyester screen and at least one layer of a nonwoven fibrous web.  
     
     
         62 . The filter device of claim  61  wherein the particle trap comprises at least one layer of a wet-laid polyethylene terephthalate medium and at least one polyester screen.  
     
     
         63 . A filter device for depleting leukocytes from leukocyte-containing blood products comprising: 
 a housing having an inlet and an outlet and having one or more layers of leukocyte depletion filtration media disposed therein, said media comprising a matrix of fibers and a plurality of components having a specific surface area of at least 120 m 2 /gm distributed amongst the matrix of fibers wherein during use said filtration media removes at least 99.99% of leukocytes;    a prefilter, located upstream of said one or more layers of leukocyte depletion media, having a layer of needle punched fabric; and    a particle trap located downstream of said one or more layers of leukocyte depletion media, having a first thin polyester screen, a layer of non-woven polyester, and a second thin polyester screen.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.